University of the Sciences

Tris Pharma Appoints Michael Magee as Vice President, Quality & Compliance

Retrieved on: 
Wednesday, February 7, 2024

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced the appointment of Michael Magee as vice president, quality and compliance.

Key Points: 
  • Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced the appointment of Michael Magee as vice president, quality and compliance.
  • Mr. Magee will lead and further strengthen Tris Pharma’s continued development and management of quality and compliance operations via the current Good Manufacturing Practices (cGMP) Compliance function of the organization.
  • “Michael brings a wealth of knowledge and a deep understanding of the regulatory and quality landscape, which will be instrumental in maintaining our unwavering commitment to developing therapeutics of the highest quality across ADHD, pain, addiction and neurological disorders,” said Nicholas Cappuccino, Ph.D., chief quality officer, senior vice president of quality & compliance at Tris Pharma.
  • “I look forward to collaborating with Michael to further elevate our quality assurance and regulatory compliance practices.”

Saint Joseph's University and Pennsylvania College of Health Sciences Complete Landmark Merger, Bolstering Healthcare Education Offerings

Retrieved on: 
Friday, January 12, 2024

PHILADELPHIA and LANCASTER, Pa., Jan. 12, 2024 /PRNewswire/ -- Saint Joseph's University completed a landmark merger with Pennsylvania College of Health Sciences (PA College), resulting in the acquisition of more than 15 new nursing and allied health programs. The acquisition, which follows closely on the heels of another successful merger with University of the Sciences, further expands Saint Joseph's academic portfolio in the health sciences in the broader region and brings a bachelor's level nursing program to the University's Philadelphia location.

Key Points: 
  • "This merger not only continues PA College's legacy of excellence in healthcare education in the Lancaster community, but also allows Saint Joseph's to continue expanding our offerings in sought-after nursing and healthcare programs," said Cheryl A. McConnell, PhD , president of Saint Joseph's.
  • Both Saint Joseph's University and the Pennsylvania College of Health Sciences are dedicated to educational excellence and share a passion for advancing healthcare.
  • In addition to the merger agreement, Saint Joseph's has penned two additional agreements: one with Lancaster General Health and one with Penn Medicine.
  • Additionally, the University of Pennsylvania Health System (Penn Medicine) will reserve clinical placements in the Philadelphia metropolitan area for Saint Joseph's Hawk Hill nursing students.

Ted Kramm Appointed To BioMatrix Specialty Pharmacy Board Of Directors

Retrieved on: 
Monday, January 8, 2024

PLANTATION, Fla., Jan. 8, 2024 /PRNewswire/ -- BioMatrix Specialty Pharmacy is pleased to announce the appointment of Ted Kramm to the Board of Directors. 

Key Points: 
  • PLANTATION, Fla., Jan. 8, 2024 /PRNewswire/ -- BioMatrix Specialty Pharmacy is pleased to announce the appointment of Ted Kramm to the Board of Directors.
  • "We are excited to welcome Ted Kramm to the Board of BioMatrix Specialty Pharmacy," said Nick Karalis, Board Chair.
  • "Ted's immense experience in the home infusion industry will be invaluable to BioMatrix as we continue to grow and focus on specialty infusion services.
  • Kramm is a pharmacist and holds a bachelor's degree from Philadelphia College of Pharmacy, now part of St. Joseph's University.

Cheryl A. McConnell, PhD, Inaugurated as 29th President of Saint Joseph's University

Retrieved on: 
Friday, September 8, 2023

PHILADELPHIA, Sept. 8, 2023 On Friday, Saint Joseph's University inaugurated Cheryl A. McConnell, PhD , as the 29th — and first female — president in the University's 172-year history.

Key Points: 
  • PHILADELPHIA, Sept. 8, 2023 On Friday, Saint Joseph's University inaugurated Cheryl A. McConnell, PhD , as the 29th — and first female — president in the University's 172-year history.
  • Cheryl is a first-generation college graduate who has immersed herself in the twin Jesuit traditions of spirituality and of service."
  • The Mass, which is a ceremonial start of the school year, was also the inaugural Mass for President McConnell.
  • As interim president, she finalized another merger agreement with the Pennsylvania College of Health Sciences , expected to close in January 2024.

Elucida Oncology Appoints Ramzi Benamar as Chief Financial Officer

Retrieved on: 
Thursday, August 24, 2023

MONMOUTH JUNCTION, N.J., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that Ramzi Benamar, a seasoned financial leader with a proven track record in the life sciences industry, has been appointed as Chief Financial Officer, effective September 1, 2023.

Key Points: 
  • MONMOUTH JUNCTION, N.J., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that Ramzi Benamar, a seasoned financial leader with a proven track record in the life sciences industry, has been appointed as Chief Financial Officer, effective September 1, 2023.
  • Prior to Elucida, Mr. Benamar was the Chief Financial Officer of BELLUS Health, a clinical-stage biotech company that was recently acquired by GSK PLC for $2 billion.
  • Prior to BELLUS Health, he was Chief Financial Officer of DBV Technologies, where he led the global finance team and raised over $160 million.
  • I look forward to becoming part of the Elucida team and contributing to further advance the CDC platform,” commented Ramzi Benamar.

Santa Clara University Names Zenobia Lane as Vice President for Human Resources

Retrieved on: 
Tuesday, March 21, 2023

Santa Clara University has hired higher-education and nonprofit-industry professional Zenobia Lane to be the University’s first human resources vice president— a role she has held on an interim basis since August 2022.

Key Points: 
  • Santa Clara University has hired higher-education and nonprofit-industry professional Zenobia Lane to be the University’s first human resources vice president— a role she has held on an interim basis since August 2022.
  • Lane previously served in human-resources leadership roles in Pennsylvania at Saint Joseph’s University and at Swarthmore College.
  • As interim VP of HR at Santa Clara, she helped the University successfully implement the first phase of a market-adjustment compensation review for over 1,800 staff members.
  • Before Santa Clara, Lane served as vice president and chief human resources officer at the Jesuit-founded Saint Joseph’s University in Philadelphia, where she provided leadership in all human resources matters and was an adviser and member of the President’s University Leadership Council.

CHERYL A. MCCONNELL, PHD ELECTED FIRST WOMAN TO LEAD SAINT JOSEPH'S UNIVERSITY

Retrieved on: 
Friday, March 10, 2023

PHILADELPHIA , March 10, 2023 /PRNewswire/ -- Today, Saint Joseph's University's Board of Trustees elected Cheryl A. McConnell, PhD, its 29th – and first female– president in the University's 172-year history, effective immediately. Dr. McConnell is a 35-year veteran of Jesuit higher education, having most recently served as Saint Joseph's interim president since last June, and as provost and chief academic officer for three years prior.

Key Points: 
  • PHILADELPHIA , March 10, 2023 /PRNewswire/ -- Today, Saint Joseph's University's Board of Trustees elected Cheryl A. McConnell, PhD, its 29th – and first female– president in the University's 172-year history, effective immediately.
  • "Cheryl has strong business acumen, deep higher education experience, a career marked by dedicated commitment to our Jesuit mission and exceptional leadership skills.
  • Before her arrival at Saint Joseph's, McConnell held several leadership positions at Rockhurst University, a Jesuit institution in Kansas City, Missouri.
  • She went on to earn a PhD in higher education administration from fellow Jesuit institution Saint Louis University.

Tech Elevator Welcomes New Leaders, Embraces Growth

Retrieved on: 
Tuesday, October 11, 2022

Lisa Sydney will oversee all operations of the Philadelphia and Wilmington campuses, and Kevin Gadd will oversee the Columbus campus.

Key Points: 
  • Lisa Sydney will oversee all operations of the Philadelphia and Wilmington campuses, and Kevin Gadd will oversee the Columbus campus.
  • Were incredibly excited to welcome these two new leaders to the Tech Elevator team, said Anthony Hughes, CEO and Co-Founder, Tech Elevator.
  • Tech Elevator, a Stride Company (NYSE: LRN), is an intensive educational provider helping individuals and companies acquire in-demand technology skills for the modern workforce.
  • Founded in 2015 with a focus on quality and care in everything we do, Tech Elevator has placed over 3,000 graduates into software development roles in over 750 companies nationwide.

ProKidney Appoints Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations

Retrieved on: 
Wednesday, August 31, 2022

WINSTON-SALEM, N. C., Aug. 31, 2022 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the appointment of Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations. Dr. Schulman, who will report to Chief Financial Officer James Coulston, joins ProKidney after leading investor relations and corporate communication efforts at a number of early and late-stage Nasdaq-listed biopharmaceutical companies focused on the development of therapies to treat diseases of the immune system and kidneys.

Key Points: 
  • WINSTON-SALEM, N. C., Aug. 31, 2022 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (ProKidney), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the appointment of Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations.
  • James Coulston, CFO of ProKidney, said: On behalf of our team, I am excited to welcome Glenn to ProKidney.
  • Prior to joining ProKidney, Dr. Schulman served as Vice President of Investor Relations at X4 Pharmaceuticals.
  • Previous to that, Dr. Schulman was Senior Vice President, Investor Relations and Corporate Communications at Aurinia Pharmaceuticals; Executive Director, Investor Relations and Corporate Communications at Achillion Pharmaceuticals; and Director of Investor Relations and Medical Communications at CuraGen Corporation.

Saint Joseph’s University Puts the Consumer at the Center of its New Department of Food, Pharma and Healthcare

Retrieved on: 
Wednesday, July 27, 2022

To better address the needs and desires of this new consumer, the Erivan K. Haub School of Business at Saint Josephs University is combining three customer-focused disciplines to create The Department of Food, Pharma and Healthcare .

Key Points: 
  • To better address the needs and desires of this new consumer, the Erivan K. Haub School of Business at Saint Josephs University is combining three customer-focused disciplines to create The Department of Food, Pharma and Healthcare .
  • The Department of Food, Pharma and Healthcare is dedicated to preparing students for successful careers in the food, pharmaceutical and healthcare industries.
  • Saint Josephs University and the Haub School have long had robust connections to the global marketplace, which provides our graduates with a proven advantage.
  • Founded in 1851 as Philadelphias Jesuit university, Saint Josephs University prepares students for a rapidly changing world by focusing on academic excellence and courageous exploration.